Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections

Applied and Environmental Microbiology

Volumn 77, Issue 24, 2011, Pages 8775-8783

  Muñoz, José Antonio Moreno ^a   Chenoll, Empar ^b   Casinos, Beatriz ^b   Bataller, Esther ^b   Ramón, Daniel ^b   Genovés, Salvador ^b   Montava, Rebeca ^c   Ribes, Juan Manuel ^c   Buesa, Javier ^c   Fàbrega, Joan ^a   Rivero, Montserrat ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BALB/C MICE; BIFIDOBACTERIUM LONGUM; CELL LINES; CULTURE COLLECTION; DEVELOPED COUNTRIES; IN-VITRO; IN-VIVO; METABOLITE PRODUCTION; NOVEL STRAINS; PREVENTIVE AGENTS; PROBIOTICS; ROTAVIRUSES; SAFETY STATUS; VIRUS INFECTION;

ADHESION; MAMMALS; SODIUM CHLORIDE; VIRUSES;

CELL CULTURE;

BACTERIAL DNA; PROBIOTIC AGENT;

ADHESION; BACTERIAL DISEASE; BREASTFEEDING; CHILD HEALTH; DEVELOPING WORLD; FECES; HEALTH RISK; INFECTIOUS DISEASE; PH; PROBIOTICS; SODIUM CHLORIDE; VACCINATION; VIRAL DISEASE;

ANIMAL; ANTIBIOSIS; ARTICLE; BAGG ALBINO MOUSE; BIFIDOBACTERIUM; CELL LINE; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; FECES; FOOD SAFETY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; ROTAVIRUS; ROTAVIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIBIOSIS; BIFIDOBACTERIUM; CELL LINE; DNA, BACTERIAL; FECES; FOOD SAFETY; HUMANS; INFANT; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROBIOTICS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA; VIRUS REPLICATION;

EID: 83155182608     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.05548-11     Document Type: Article

References (52)

1. Andres, A., S. M. Donovan, T. B. Kuhlenschmidt, and M. S. Kuhlenschmidt. 2007. Isoflavones at concentrations present in soy infant formula inhibit rotavirus infection in vitro. J. Nutr. 137:2068-2073.
2. Asensi, M. T., C. Martínez-Costa, and J. Buesa. 2006. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity. J. Pediatr. Gastroenterol. Nutr. 42:560-567.
3. Bojsen, A., et al. 2007. Inhibitory activities of bovine macromolecular whey proteins on rotavirus infections in vitro and in vivo. J. Dairy Sci. 90:66-74.
4. Botíc, T., T. D. Klingberg, H. H. Weingartl, and A. Cencič. 2007. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int. J. Food Microbiol. 115:227-234.
5. Chenoll, E., et al. 2011. Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Appl. Environ. Microbiol. 77:1335-1343.
6. Colbère-Garapin, F., et al. 2007. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria. Microbes Infect. 9:1623-1631.
7. D'Aimmo, M. R., M. Modesto, and B. Biavati. 2007. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products. Int. J. Food Microbiol. 115:35-42.
8. Delgado, S., E. O'sullivan, G. Fitzgerald, and B. Mayo. 2008. In vitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates. J. Appl. Microbiol. 104:1119-1127.
9. Demirjian, A., and O. Levy. 2009. Safety and efficacy of neonatal vaccination. Eur. J. Immunol. 39:36-46.
10. Dennehy, P. H. 2008. Rotavirus vaccines: an overview. Clin. Microbiol. Rev. 21:198-208.
11. Dubey, A. P., K. Rajeshwari, A. Chakravarty, and G. Famularo. 2008. Use of VSL3 in the treatment of rotavirus diarrhea in children: preliminary results. J. Clin. Gastroenterol. 42(Suppl.):S126-S129.
12. Eerola, S., R. Hinkkanen, E. Lindfors, and T. Hirvi. 1993. Liquid chromatographic determination of biogenic amines in dry sausages. J. AOAC Int. 76:575-577.
13. Estes, M. K., and A. Kapikian. 2007. Rotaviruses, p. 1946-1974. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
14. European Food Safety Authority. 2008. Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA J. 732:1-15.
15. European Food Safety Authority. 2008. Scientific opinion of the Panel on Biological Hazards on the maintenance of the list of QPS microorganisms intentionally added to food or feed. EFSA J. 923:30-48.
16. FAO/WHO. 2001. Health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. FAO, Córdoba, Argentina.
17. FAO/WHO. 2002. Draft guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group meeting, London, Ontario, Canada 30 April-1 May 2002. World Health Organization, Geneva, Switzerland.
18. Freitas, M., et al. 2003. Host pathogens cross-talk: indigenous bacteria and probiotics also play the game. Biol. Cell 95:503-506.
19. Fukushima, Y., Y. Kawata, H. Hara, A. Terada, and T. Mitsuoka. 1998. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol. 42:39-44.
20. Glass, R. I., et al. 2006. Rotavirus vaccines: current prospects and future challenges. Lancet 368:323-332.
21. Gonçalves, J. L., et al. 2005. In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea. J. Ethnopharmacol. 99:403-407.
22. Greenberg, H. B., and M. K. Estes. 2009. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136:1939-1951.
23. Guandalini, S., et al. 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European study. J. Pediatr. Gastroenterol. Nutr. 30:54-60.
24. Haarman, M., and J. Knol. 2005. Quantitative real-time PCR assays to identify and quantify fecal bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 71:2318-2324.
25. He, T., et al. 2008. Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. J. Appl. Microbiol. 104:595-604.
26. Izquierdo, I., M. Medina, S. Ennahar, E. Marchioni, and Y. Sanz. 2008. Resistance to simulated gastrointestinal conditions and adhesion to mucus as probiotic criteria for Bifidobacterium longum strains. Curr. Microbiol. 56: 613-618.
27. Kapikian, A. Z., Y. Hoshino, and R. M. Chanock. 2001. Rotaviruses, p. 1787-1833. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven, Philadelphia, PA.
28. Klare, I., et al. 2005. Evaluation of new broth media for microdilution antibiotic susceptibility testing of lactobacilli, pediococci, lactococci, and bifidobacteria. Appl. Environ. Microbiol. 71:8982-8986.
29. Kumar, R. S., et al. 2006. Structural and functional analysis of a conjugated bile salt hydrolase from Bifidobacterium longum reveals an evolutionary relationship with penicillin V acylase. J. Biol. Chem. 281:32516-32525.
30. Labadie, K., I. Pelletier, A. Saulnier, J. Martin, and F. Colbère-Garapin. 2004. Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells. Virology 318:66-78.
31. Liakatos, A., M. J. Kiefel, F. Fleming, B. Coulson, and M. von Itzsteina. 2006. The synthesis and biological evaluation of lactose-based sialylmimetics as inhibitors of rotaviral infection. Bioorg. Med. Chem. 14:739-757.
32. Lundgren, O., et al. 2000. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 287:491-495.
33. McNeal, M. M., J. Belli, M. Basu, A. H. Choi, and R. Ward. 2004. Discovery of a new strain of murine rotavirus that is consistently shed in large quantities after oral inoculation of adult mice. Virology 320:1-11.
34. Meile, L., G. Le Blay, and A. Thierry. 2008. Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium. Int. J. Food Microbiol. 126:316-320.
35. Minocha, A. 2009. Probiotics for preventive health. Nutr. Clin. Pract. 24: 227-241.
36. Misra, S., T. K. Sabui, and N. K. Pal. 2009. A randomized controlled trial to evaluate the efficacy of Lactobacillus GG in infantile diarrhea. J. Pediatr. 155:129-132.
37. Mohan, R., et al. 2008. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr. Res. 64:418-422.
38. Nebra, Y., and A. R. Blanch. 1999. A new selective medium for Bifidobacterium spp. Appl. Environ. Microbiol. 65:5173-5176.
39. Parashar, U. D., C. J. Gibson, M. A. Bresee, and R. I. Glass. 2006. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis. 12:304-306.
40. Phua, K. B., et al. 2009. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 27:5936-5941.
41. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
42. Reid, G. 2008. Probiotic lactobacilli for urogenital health in women. J. Clin. Gastroenterol. 42(Suppl):S234-S236.
43. Ritter, P., C. Kohler, and U. von Ah. 2009. Evaluation of the passage of Lactobacillus gasseri K7 and bifidobacteria from the stomach to intestines using a single reactor model. BMC Microbiol. 9:87.
44. Saavedra, J. M., N. A. Bauman, I. Oung, J. A. Perman, and R. H. Yolken. 1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046-1049.
45. Salazar, N., et al. 2009. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. Int. J. Food Microbiol. 135:260-267.
46. Sarker, S. A., et al. 2005. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of non-rotavirus diarrhea in children from Bangladesh. Pediatrics 116:e221-e228.
47. Tanaka, H., H. Hashiba, J. Kok, and I. I. Mierau. 2000. Bile salt hydrolase activity of Bifidobacterium longum: biochemical and genetic characterization. Appl. Environ. Microbiol. 66:2502-2512.
48. Van de Perre, P. 2003. Transfer of antibody via mother's milk. Vaccine 21:3374-3376.
49. Vesikari, T., et al. 2007. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370:1757-1763.
50. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1990. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:5070-5075.
51. Wilfinger, W., M. Mackey, and P. Chanczynski. 1997. Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques 22:474-480.
52. Williams, C. J., A. Lobanov, and R. G. Pebody. 2009. Estimated mortality and hospital admission due to rotavirus infection in the WHO European region. Epidemiol. Infect. 137:607-616.